SCHEMBL8620636

SCHEMBL8620636

COc1cccc2nccc(C(=O)NC(N)=Nc3ccccc3)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
LMNA P02545 2/20 0.49
PSMD14 O00487 1/20 0.49
SMO Q99835 9/20 0.45
PREP P48147 1/20 0.43
IMPDH2 P12268 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
SCNN1A P37088 1/20 0.40
ADORA2A P29274 1/20 0.40
TGFBR1 P36897 1/20 0.40
SCN5A Q14524 1/20 0.39
SCN2A Q99250 1/20 0.39
STAT6 P42226 2/20 0.39
HIF1A Q16665 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GMNN O75496 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8618659 0.89 NPC1 (0.41) NPC1RAB9ALMNAPSMD14SMO
SCHEMBL8617949 0.87 SMO (0.46) NPC1RAB9ALMNAPSMD14SMO
SCHEMBL8618668 0.86 SMO (0.43) NPC1RAB9ALMNAPSMD14SMO
SCHEMBL8614354 0.86 SMO (0.43) NPC1RAB9ALMNAPSMD14SMO
Hydrochloric Acid SCHEMBL8615174 0.85 SMO (0.42) NPC1RAB9ALMNAPSMD14SMO
SCHEMBL8618940 0.85 ADORA2A (0.44) NPC1RAB9ALMNAPSMD14SMO
SCHEMBL8619835 0.84 SMO (0.49) NPC1RAB9ALMNAPSMD14SMO
SCHEMBL8613364 0.84 PIK3CA (0.47) NPC1RAB9ALMNAPSMD14SMO
SCHEMBL8617728 0.84 RAB9A (0.43) NPC1RAB9ALMNAPSMD14SMN1; SMN2
SCHEMBL8616601 0.83 RAB9A (0.47) NPC1RAB9ALMNAPSMD14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed